BANK OF AMERICA CORP /DE/
BankPosition in IOVA — Iovance Biotherapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,773,308
-$9,027,008 QoQ
Shares Held
4,993,584
-41.2% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Derivatives in IOVA
reported options exposure · as of Sep 30, 2022CallValue
$466,546
CallShares
48,700
PutValue
$466,546
PutShares
48,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. IOVA ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IOVA
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,773,308 | 4,993,584 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,800,316 | 8,490,119 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $38,978,427 | 14,277,813 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,625,928 | 6,279,230 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $6,930,855 | 4,029,568 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,047,223 | 3,017,185 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,486,491 | 741,418 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,013,365 | 2,450,838 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,381,140 | 2,167,225 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,708,742 | 1,532,304 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,616,890 | 936,887 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,596,809 | 1,230,068 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,112,158 | 1,294,341 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,754,227 | 1,432,771 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,543,596 | 1,180,532 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $466,546 | 48,700 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $5,433,927 | 567,216 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $466,546 | 48,700 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $3,473,689 | 314,646 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,036,376 | 1,023,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,097,971 | 790,884 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $13,712,683 | 556,070 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,984,549 | 460,590 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $82,517,227 | 2,606,356 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $148,594,512 | 3,202,468 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $106,385,750 | 3,231,645 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $89,503,137 | 3,260,588 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $96,227,726 | 3,214,019 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||